FDA approves pretomanid for highly drug-resistant forms of TB

Pretomanid receives FDA approval in combination regimen with bedaquiline and linezolid for people with XDR-TB or treatment-intolerant/non-responsive MDR-TB.

Read More →

Practice-based recommendations for the management of RR/MDR-TB

Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB. 

Read More →

TAG’s 2019 Pipeline Report: Pediatric TB section released

The section provides an overview of research and development of innovations for diagnosing, preventing, treating TB in children.

Read More →

Declaration of the Rights of People Affected by TB now available in French, Spanish and Russian

The Declaration was launched in May 2019 by TBpeople in partnership with the Stop TB Partnership.

Read More →

Update of WHO guidelines on the programmatic management of drug-resistant TB

End-users (i.e. policy makers; health professionals, including doctors, nurses and educators working in governmental and non-governmental organizations; TB patients) interested in providing comments on the scope of this guideline update are invited to submit their feedback.

Read More →

Time to act on the 2018 TB commitments

The Stop TB Partnership, the Global Fund to Fight AIDS, TB and Malaria and the World Health Organization call for immediate action to implement the commitments made by Head of States and Governments at the UN High-Level Meeting on TB.

Read More →

Public call for individual patient data on treatment of drug-resistant TB

The World Health Organization issues a public call for individual patients data on rifampicin-resistant and multidrug-resistant TB treatment outcomes.

Read More →

WHO Director-General calls for urgent country action to meet End TB targets

WHO Director-General calls for urgent country action to meet UN High-Level Meeting on TB targets in letters to Heads of State.

Read More →

Transparency and access to pretomanid and the Nix-TB regimen

Advocates request responsible investment in pretomanid promoting transparency and equitable access.

Read More →

Activists demand universal access to medicines — science must benefit all!

Life without medicines is no party: Activists call on governments across the world to join the #Science4All “party” to make treatment available to all.

Read More →

Page 1 of 99 · Total posts: 10

1 2 Last→